NL-OMON53368招募中2 期
Short-term safety and efficacy of ketohexokinase inhibition in patients with hereditary fructose intolerance - Ketohexokinase inhibition in hereditary fructose intolerance
Medisch Universitair Ziekenhuis Maastricht0 个研究点目标入组 8 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 8
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Participants are able to provide signed and dated written informed consent
- •prior to any study specific procedures
- •Use of effective contraception (only applicable to premenopausal women)
- •Aged >= 18 years
排除标准
- •Type 2 diabetes
- •Patients with congestive heart failure and/or severe renal and/or liver
- •insufficiency
- •Uncontrolled hypertension
- •Previous enrolment in a clinical study with an investigational product during
- •the last 3 months or as judged by the investigator which would possibly hamper
- •our study results
- •Use of drugs that inhibit organic anion transporting polypeptide (OATP)
- •transporters (e.g. rifampicin, gemfibrozil, cyclosporine, erythromcyin and
- •clarithromycin)*
- •Subjects who do not want to be informed about unexpected medical findings
- •* Exclusion criterion for HFI patients only.
研究者
相似试验
招募中
2 期
Metabolic effects of ketohexokinase inhibition in individuals with non-alcoholic fatty liver diseasenon-alcoholic fatty liver disease100184241001965410012653fatty liverNL-OMON51756niversiteit Maastricht17
尚未招募
2 期
Clinical Study on the effect of Ksheera Sandava seka on Eye FatigueCTRI/2023/07/054639Amrita School Ayurveda
进行中（未招募）
不适用
Efficacy and Tolerability of Ketomousse, Ketoconazole 1 , Salicilic Acid and Zinc phyritione thermolabile foam in the treatment of Pityriasis Versicolor in comparison with Ketoconazole 2 cream NizoralPITYRIASIS VERSICOLORMedDRA version: 6.1Level: PTClassification code 10056131EUCTR2005-000785-39-ITMIPHARM60
已完成
2 期
Ketohexokinase Inhibition in Hereditary Fructose IntoleranceHFINCT06089265Maastricht University Medical Center8
已完成
1 期
Study on the safety and efficacy of the ketogenic diets for stage IV advanced and recurrent cancer patients.JPRN-UMIN000039925Tama-Nanbu Regional Hospital, Tokyo Metropolitan Health and Medical Treatment Corporation Department of Surgery30